Skip to main content
LGND
NASDAQ Life Sciences

Ligand Posts $1.43 Per-Share Q3 Loss as Royalty Story Faces First Test

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$311.87
Mkt Cap
$6.355B
52W Low
$175.89
52W High
$326.63
52W Position info
77% above low
Off High info
4.5% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

LGND sits 77% above its 52-week low of $175.89.

Summary

Ligand reported a third-quarter loss of $1.43 per share, or $28.5M, a sharp swing from the profitable second quarter when net income hit $48.5M on $63.7M of revenue, while adjusted earnings came in at $2.67 per share. The loss lands just weeks after the company closed its XOMA Royalty acquisition, which the September 8-K/A showed carried a $41.2M first-half loss of its own, so the red ink likely reflects deal-related and non-cash items rather than a collapse in the royalty base. The stock trades near its 52-week high at $311.87, so expectations were high and any sign of royalty deceleration will be punished. The headline gives only the per-share loss and adjusted EPS — no revenue, royalty growth, or guidance — so the full read depends on the release details and call. Watch whether Ligand reaffirms the raised full-year royalty outlook it issued with Q2; that is the number that matters for the thesis.

At the time of this announcement, LGND was trading at $311.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $175.89 to $326.63. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LGND - Latest Insights

LGND
Oct 30, 2026, 4:47 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $324.00
Real-time Price: $308.70 info
Change: -$15.30 (-5%) info
Market Cap: $6.177B info
LGND
Oct 29, 2026, 3:12 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $316.21
Real-time Price: $308.70 info
Change: -$7.51 (-2%) info
Market Cap: $6.177B info
LGND
Oct 29, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $311.87
Real-time Price: $308.70 info
Change: -$3.17 (-1%) info
Market Cap: $6.177B info
LGND
Sep 24, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $298.41
Real-time Price: $308.70 info
Change: +$10.29 (+3%) info
Market Cap: $6.177B info
LGND
Sep 22, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $290.00
Real-time Price: $308.70 info
Change: +$18.70 (+6%) info
Market Cap: $6.177B info